GenMark Diagnostics Inc. (NASDAQ: GNMK) flaunted slowness of -6.01% at $14.55, as the Stock market unbolted on January 12, 2021. During the day, the stock rose to $17.075 and sunk to $14.42 before settling in for the price of $15.48 at the close. Taking a more long-term approach, GNMK posted a 52-week range of $3.36-$20.88.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 23.50%. Meanwhile, its Annual Earning per share during the time was 2.30%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 9.40%. This publicly-traded company’s shares outstanding now amounts to $71.10 million, simultaneously with a float of $68.64 million. The organization now has a market capitalization sitting at $1.04 billion. At the time of writing, stock’s 50-day Moving Average stood at $13.89, while the 200-day Moving Average is $12.92.
If we measure the efficiency of the company that is accounted for 437 employees. It has generated 201,421 per worker during the last fiscal year. Meanwhile, its income per employee was -108,352. The stock had 6.22 Receivables turnover and 0.86 Total Asset turnover. For the Profitability, stocks gross margin was +32.50, operating margin was -47.50 and Pretax Margin of -53.72.
GenMark Diagnostics Inc. (GNMK) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the GenMark Diagnostics Inc. industry. GenMark Diagnostics Inc.’s current insider ownership accounts for 3.20%, in contrast to 98.70% institutional ownership. According to the most recent insider trade that took place on Jan 07, this organization’s SVP, Engineering and Tech Dev sold 32,477 shares at the rate of 16.99, making the entire transaction reach 551,784 in total value, affecting insider ownership by 190,008. Preceding that transaction, on Jan 06, Company’s SVP, Engineering and Tech Dev sold 16,823 for 16.00, making the whole transaction’s value amount to 269,168. This particular insider is now the holder of 190,985 in total.
GenMark Diagnostics Inc. (GNMK) Earnings and Revenue Records
Going through the last 3-months fiscal report unveiled on the 9/29/2020, it has been observed that the corporation posted -$0.05 earnings per share (EPS) during the time that was better the consensus figure (set at -$0.06) by $0.01. This company achieved a net margin of -53.79 while generating a return on equity of -207.18. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
GenMark Diagnostics Inc.’s EPS increase for this current 12-month fiscal period is 9.40% and is forecasted to reach -0.07 in the upcoming year.
GenMark Diagnostics Inc. (NASDAQ: GNMK) Trading Performance Indicators
Let’s observe the current performance indicators for GenMark Diagnostics Inc. (GNMK). It’s Quick Ratio in the last reported quarter now stands at 3.80. The Stock has managed to achieve an average true range (ATR) of 0.99. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 7.00.
In the same vein, GNMK’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.41, a figure that is expected to reach -0.02 in the next quarter, and analysts are predicting that it will be -0.07 at the market close of one year from today.
Technical Analysis of GenMark Diagnostics Inc. (GNMK)
Now, what If we examine the latest scores posted by [GenMark Diagnostics Inc., GNMK]. During the last 5-days, its volume was better the volume of 0.87 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 42.34% While, its Average True Range was 1.11.
Raw Stochastic average of GenMark Diagnostics Inc. (GNMK) in the period of the previous 100 days is set at 56.59%, which indicates a major rise in contrast to 17.21% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 58.21% that was lower than 63.70% volatility it exhibited in the past 100-days period.